GATA3 and neoplasm: Other clinicopathological characteristics that were associated with GATA3 mutation status in this patient cohort (Table 1) are the following: pathologic tumor size was significantly different between patients with GATA3 mutant tumors compared to patients with wild-type GATA3 tumors (p = 0.01).